Devyser secures a major SEK 16.8M tender in Italy with 30% growth
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
We help laboratories focus on what matters most to patients – correct and fast diagnosis every time. Our genetic test kits with integrated software set new standards in DNA diagnostic testing.
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden
News | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in ChinaDevyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Read more
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read more
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read more
Read more